Opportunity ID: 52267

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-10-NFRP-PTA
Funding Opportunity Title: DoD Neurofibromatosis Postdoctoral Traineeship Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 4
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Mar 02, 2010
Last Updated Date:
Original Closing Date for Applications: May 20, 2010
Current Closing Date for Applications: May 20, 2010
Archive Date: Jun 19, 2010
Estimated Total Program Funding: $600,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description: The NFRP Postdoctoral Traineeship Award mechanism was first offered in FY09. Since then, 8 Postdoctoral Traineeship Award applications have been received, and 4 have been recommended for funding. The intent of the training award is to enable recent medical or other doctoral degree graduates to obtain the necessary experience to pursue an independent career in NF research. Candidates for this award should exhibit a strong desire to pursue a career in NF research.
Under this award mechanism, the postdoctoral trainee is considered the Principal Investigator (PI) and, as such, should write the project narrative with appropriate direction from the mentor. The focus of these awards is on the PI, the mentor, and the training program and environment. These awards primarily provide salary support for the PI and require the active involvement of a designated mentor who is an established NF researcher, as evidenced by a demonstrated record of funding and publications. While the PI is not required to have previous experience in NF research, applications for this award must focus on NF research.
DOD FY10 Neurofibromatosis Postdoctoral Traineeship Award 3
Areas of Encouragement: The FY10 NFRP encourages applications that specifically address the critical needs of the NF community in the following areas:
• Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities;
• Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain;
• Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and
• Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF.
Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil

eReceipt HELP: 301-682-5507; help@cdmrp.org

Email:cdmrp.pa@amedd.army.mil

Version History

Version Modification Description Updated Date

Folder 52267 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf

Folder 52267 Full Announcement-1 -> fy10 nfrp statement of eligibility pta.pdf

Folder 52267 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf

Folder 52267 Full Announcement-1 -> nfrp_fy10 pta pa_gg.pdf

Packages

Agency Contact Information: PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org

Email: cdmrp.pa@amedd.army.mil

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00016815 Mar 02, 2010 May 20, 2010 View

Package 1

Mandatory forms

52267 RR_SF424_1_2-1.2.pdf

52267 PerformanceSite_1_4-1.4.pdf

52267 RR_KeyPersonExpanded_1_2-1.2.pdf

2025-07-11T06:23:12-05:00

Share This Post, Choose Your Platform!

About the Author: